Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for scientists.

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.